Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Personalized medicine in diabetes: the role of ‘omics’ and biomarkers

23 Jan 2016

Abstract excerpt

Personalized medicine, otherwise called stratified or precision medicine, aims to better target intervention to the individual to maximize benefit and minimize harm. This review discusses how diabetes aetiology, pathophysiology and patient genotype influence response to or side effects of the commonly used diabetes treatments. C-peptide is a useful biomarker that is underused to guide treatment choice, severe...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Treatment and Management
Share to Metabolism, Diabetes, and Cancer
Share to Pancreatic function and diabetes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26802434
DOI: 10.1111/dme.13075

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Personalized medicine in diabetes: the role of ‘omics’ and biomarkersPMID 26802434Read ↗

Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical PracticeSemantic proximity Read ↗

Pharmacogenetics and target identification in diabetes.Semantic proximity Read ↗

Diabetes: Is There a Future for Pharmacogenomics Guided Treatment?Semantic proximity Read ↗

Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicineSemantic proximity Read ↗

Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?Semantic proximity Read ↗

Current Progress in Pharmacogenetics of Second-Line Antidiabetic Medications: Towards Precision Medicine for Type 2 DiabetesSemantic proximity Read ↗

Personalized medicine in diabetes mellitus: current opportunities and future prospectsSemantic proximity Read ↗

Personalized medicine in diabetes.Semantic proximity Read ↗

Pharmacogenetic studies update in type 2 diabetes mellitusSemantic proximity Read ↗

Current progress in pharmacogenomics of Type 2 diabetes: A systemic overview.Semantic proximity Read ↗

Genomic medicine at the heart of diabetes management.Semantic proximity Read ↗

Pharmacogenetics of metformin response: a step in the path toward personalized medicine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.